GW Pharma (GWPH) Posts 1 Loss of 2.2c/Share

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($0.02), $1.23 better than the analyst estimate of ($1.25). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $12.12 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Cloudastructure reports 164% subscription revenue growth in Q2 2026
• DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings